EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2023 (TTM): S$0.12

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is S$0.19. In 2022 the company made an earnings per share (EPS) of S$0.12 a decrease over its 2021 EPS that were of S$0.14.

EPS history for Jiangsu Hengrui Medicine from 2002 to 2023

Annual EPS

Year	EPS	Change
2023 (TTM)	S$0.12	6.36%
2022	S$0.12	-17.1%
2021	S$0.14	-24.44%
2020	S$0.19	20.3%
2019	S$0.15	25.58%
2018	S$0.12	27.55%
2017	S$0.09667	21.64%
2016	S$0.07948	13.57%
2015	S$0.06998	39.86%
2014	S$0.05003	21.33%
2013	S$0.04124	17.7%
2012	S$0.03504	25.56%
2011	S$0.02790	26.22%
2010	S$0.02211	10.3%
2009	S$0.02004	57.92%
2008	S$0.01269	11.06%
2007	S$0.01143	85.81%
2006	S$0.006150	87.94%
2005	S$0.003272	33.97%
2004	S$0.002442	29.78%
2003	S$0.001882	19.78%
2002	S$0.001571

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions